Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis

Globe Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

- Company preparing to dose first patients in pivotal Phase 3 ASCEND clinical trial -

BASKING RIDGE, NJ, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSEAmerican:TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TMB-001, a topical isotretinoin formulated using the Company’s patented IPEG™ delivery system, for the treatment of congenital ichthyosis (CI). 

Read more at globenewswire.com

Related Symbols

Symbol Last Chg %Chg
TMBR 0.3426 +0.0025 +0.74%
Timber Pharmaceuticals Inc

Most Popular News

Super Micro Computer Inc logo on building-by Poetra_RH via Shutterstock 1
Super Micro Computer Stock Tumbles, But Investors are Piling into Its Call Options - Time to Buy SMCI?
Wall street sign in New York with New York Stock Exchange background by Stuart Monk via Shutterstock 2
Stock Index Futures Muted in Thin Pre-Christmas Trade, U.S. Jobless Claims Data on Tap
Road sign of New York Wall street corner Broad street by Mezzotint via Shutterstock 3
Stocks Little Changed Heading Into Year-End
Disneyland - by EnchantedFairy via iStock 4
Disney Insider James Gorman Just Bought $2 Million of DIS Stock. Should You Load Up on Shares Too?
The logo for The Trade Desk displayed on a smartphone screen by Mamun_Sheikh via Shutterstock 5
The Worst-Performing S&P 500 Stock in 2025 Is Down 70%. Should You Buy the Dip?
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot